Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Suven presents novel candidates for cognitive deficits associated with degenerative diseases

Nov. 19, 2013

Antibody fragment-mediated eradication of hallmark Alzheimer-like pathology in transgenic mice

Nov. 19, 2013

FDA grants orphan drug designation to Epidiolex for Dravet syndrome

Nov. 18, 2013

Trk-A inhibitors reported in Ono Pharmaceutical patent

Nov. 18, 2013

UCI-50027 as a promising neuroactive steroid showing anticonvulsant and anxiolytic activity in vivo

Nov. 18, 2013

Novogen reports discovery in program for degenerative disorders

Nov. 15, 2013

FDA advisory committee recommends approval of circadian regulator tasimelteon

Nov. 15, 2013

Ono Pharmaceutical reports data from phase II/III study of ONO-2745

Nov. 15, 2013

New LRRK2 modulators patented by Genentech and Roche for Parkinson's disease

Nov. 15, 2013

Acadia Pharmaceuticals begins pimavanserin trial for Alzheimer's disease psychosis

Nov. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...